| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2718626 | The American Journal of Medicine | 2013 | 8 Pages |
Abstract
The treatment effect of ticagrelor among non-ST-segment-elevation acute coronary syndrome patients was consistently expressed across all baseline ST-segment depression strata. There was no indication of an anti-ischemic benefit of ticagrelor as reflected on the discharge ECG. Our data affirm the independent prognostic relationship of both baseline and hospital discharge ST-segment depression on outcomes within 1 year in non-ST-segment-elevation acute coronary syndrome patients.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Paul W. MD, Cynthia M. PhD, Yuling MD, Robert A. MD, Robert F. MD, DM, Hugo MD, Stefan MD, PhD, Lars MD, PhD,